{
    "startDate": "2020-04-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "ARQT",
    "data": {
        "bs": [
            {
                "label": "Clinical trial accruals",
                "concept": "arqt:ClinicalTrialAccrualCurrent",
                "unit": "usd",
                "value": 8504000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1694000
            },
            {
                "label": "Early exercise liability, current",
                "concept": "DeferredCompensationShareBasedArrangementsLiabilityCurrent",
                "unit": "usd",
                "value": 208000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 542000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 10948000
            }
        ],
        "cf": [],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 30009000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 5618000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 35627000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 35627000
            },
            {
                "label": "Other income, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 215000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 35412000
            },
            {
                "label": "Unrealized gain (loss) on marketable securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 19000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 35431000
            },
            {
                "label": "Net loss per share, basic and diluted (in USD per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": 0.94
            },
            {
                "label": "Weighted-average shares used in computing net loss per share, basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 37587330
            }
        ]
    }
}